Publications by authors named "K Andries"

Claim this Profile
M
Mice infected with . with mutations still benefit from bedaquiline treatment.
N Lounis, T Gevers, C Villellas, K Andries

IJTLD Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-MIC levels of bedaquiline and clofazimine can select mutants with increased MIC.
Cristina Villellas, Frederik Stevenaert, Bart Remmerie, Koen Andries

Antimicrob Agents Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy.
Aurélie Chauffour, Nacer Lounis, Koen Andries, Vincent Jarlier, Nicolas Veziris

PLoS Negl Trop Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
J Snobre, M C Villellas, N Coeck, W Mulders, O Tzfadia, K Andries

Sci Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mutations on patients with drug-resistant TB treated with bedaquiline.
K Kaniga, N Lounis, S Zhuo, N Bakare, K Andries

Int J Tuberc Lung Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis